Previous Close | 2.2200 |
Open | 2.2500 |
Bid | 0.0000 x 1300 |
Ask | 0.0000 x 1000 |
Day's Range | 2.1900 - 2.3250 |
52 Week Range | 1.7900 - 13.5200 |
Volume | |
Avg. Volume | 171,949 |
Market Cap | 85.048M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NEW YORK, May 13, 2022--PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. named Top 50 Healthcare Technology CEO.
NEW YORK, May 11, 2022--Lucid Diagnostics provides business update and preliminary first quarter 2022 financial results.
NEW YORK, May 09, 2022--Lucid’s first commercial payer agreement provides in-network access and payment for its EsoGuard® DNA test to over 8 million covered lives.